Voiceitt raises $10M in a Series A funding round

The voice recognition company aims to improve quality of life for those with speech and motor disabilities.
By Sara Mageit
05:03 am
Share

Credit: Voiceitt

Israel-based speech recognition technology company, Voiceitt, has successfully raised $10 million in a Series A round which closed on 30 June 2020.  

Investors included Viking Maccabee Ventures, Microsoft's M12, AMIT Technion, Cahn Capital Corp, Connecticut Innovations and AARP along with Quake Capital, SLJ Family Office, Dreamit Ventures and The Disability Opportunity Fund, bringing total funds raised to over $15 million. 

Voiceitt participated in the Alexa Accelerator, powered by Techstars in Seattle in 2018 and is an Amazon Alexa Fund portfolio company. 

WHY IT MATTERS

Voiceitt’s application enables people with severe speech impairments to communicate by voice and translates unintelligible and atypical speech in real time.

Voiceitt also aims to assist healthcare professionals and support the continuum of care for their patients in the pandemic environment.

THE LARGER CONTEXT

Several startups have used voice technology to help those with speech and hearing difficulties, with the aim of facilitating communication between patients and providers.

Competitors such as Ava and VocaliD have used natural language processing to turn spoken words into text and vice versa.

MobiHealthNews recently reported on 37 startups building voice applications for healthcare, particularly at a time when predictions show that 50 per cent of searches will be voice-based by 2020.

ON THE RECORD

Danny Weissberg, CEO and co-founder, said: "Voiceitt provides a new dimension of independence and quality of life for people with speech and motor disabilities, and a compelling tool for those who care for and about them. Our technology helps with this and much more."

"With the impact of the COVID-19 pandemic, our objectives are not only to support the individual's in-person communication, but also to assist healthcare professionals and support the continuum of care for their patients."

Share